Literature DB >> 12505818

Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care.

Anthony Bateman1, Peter Fonagy.   

Abstract

OBJECTIVE: The authors assessed health care costs associated with psychoanalytically oriented partial hospital treatment for borderline personality disorder compared with treatment as usual within general psychiatric services.
METHOD: Health care utilization of all borderline personality disorder patients who participated in a previous trial of partial hospital treatment compared with treatment as usual was assessed by using information from case notes and service providers. Costs were compared for the 6 months before treatment, 18 months of treatment, and an 18-month follow-up period.
RESULTS: There were no cost differences between the groups during pretreatment or treatment. Costs of partial hospital treatment were offset by less psychiatric inpatient care and reduced emergency room treatment. The trend for costs to decrease in the partial hospitalization group during the follow-up period was not apparent in the treatment-as-usual group.
CONCLUSIONS: Specialist partial hospital treatment for borderline personality disorder is no more expensive than treatment as usual and shows considerable cost savings after treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505818     DOI: 10.1176/appi.ajp.160.1.169

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

Review 1.  Common factors in empirically supported treatments of borderline personality disorder.

Authors:  Igor Weinberg; Elsa Ronningstam; Mark J Goldblatt; Mark Schechter; John T Maltsberger
Journal:  Curr Psychiatry Rep       Date:  2011-02       Impact factor: 5.285

2.  The Roles of Emotion Regulation Difficulties and Impulsivity in the Associations between Borderline Personality Disorder Symptoms and Frequency of Nonprescription Sedative Use and Prescription Sedative/Opioid Misuse.

Authors:  Julia R Richmond; Matthew T Tull; Kim L Gratz
Journal:  J Contextual Behav Sci       Date:  2020-03-16

3.  Mentalization based treatment for borderline personality disorder.

Authors:  Anthony Bateman; Peter Fonagy
Journal:  World Psychiatry       Date:  2010-02       Impact factor: 49.548

4.  Poor self-control and harsh punishment in childhood prospectively predict borderline personality symptoms in adolescent girls.

Authors:  Michael N Hallquist; Alison E Hipwell; Stephanie D Stepp
Journal:  J Abnorm Psychol       Date:  2015-08

Review 5.  Psychological therapies for people with borderline personality disorder.

Authors:  Jutta M Stoffers; Birgit A Völlm; Gerta Rücker; Antje Timmer; Nick Huband; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 6.  Borderline personality disorder: considerations for inclusion in the Massachusetts parity list of "biologically-based" disorders.

Authors:  Mary Ellen Foti; Jeffrey Geller; Laura S Guy; John G Gunderson; Brian A Palmer; Lisa M Smith
Journal:  Psychiatr Q       Date:  2011-06

7.  Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data.

Authors:  Katharina Bode; Rolf Vogel; Jochen Walker; Christoph Kröger
Journal:  Eur J Health Econ       Date:  2016-12-18

8.  Controversies surrounding classification of personality disorder.

Authors:  Youl-Ri Kim; Peter Tyrer
Journal:  Psychiatry Investig       Date:  2010-02-08       Impact factor: 2.505

9.  Self-Control Capacity as a Predictor of Borderline Personality Disorder Features, Problematic Drinking, and Their Co-occurrence.

Authors:  Benjamin N Johnson; Melinda L Ashe; Stephen J Wilson
Journal:  J Pers Disord       Date:  2016-04-11

10.  Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning.

Authors:  Rachel L Tomko; Timothy J Trull; Phillip K Wood; Kenneth J Sher
Journal:  J Pers Disord       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.